Product
Sulfur Hexafluoride Lipid Type A Microspheres
Aliases
Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]
3 clinical trials
4 indications
Indication
Heart DiseasesIndication
Abdominal traumaIndication
Tetralogy of FallotIndication
Pulmonary InsufficiencyClinical trial
A Phase III Crossover Study to Evaluate Bolus Versus Continuous Infusion of Lumason® in Patients With Suboptimal Unenhanced EchocardiographyStatus: Not yet recruiting, Estimated PCD: 2024-07-31
Clinical trial
Contrast Enhanced Ultrasonography for Blunt Abdominal Trauma Imaging in ChildrenStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Contrast Enhanced Three Dimensional Echocardiographic Quantification of Right Ventricular Volumes in Repaired Congenital Heart DiseaseStatus: Recruiting, Estimated PCD: 2024-07-01